Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
The DOI matches its Crossref record.
Abstract
The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The management of patients with HCC has improved markedly since the first BCLC classification was proposed in 1999143.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [143]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 1,005
Verslype, C., Rosmorduc, O., & Rougier, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds225 · Cited by 365
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Tomimaru, Y., Eguchi, H., Nagano, H., Wada, H., Kobayashi, S., Marubashi, S., Tanemura, M., Tomokuni, A., Takemasa, I., Umeshita, K., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.026 · Cited by 361
Combination immunotherapy for hepatocellular carcinoma
Rimassa, L., Finn, R. S., & Sangro, B. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.003 · Cited by 359
Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients
Planas, R., Ballesté, B., Álvarez, M. A., Rivera, M., Montoliu, S., Galeras, J. A., Santos, J., Coll, S., Morillas, R. M., & Sola, R. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.005 · Cited by 359
Recent progress in treatment of hepatocellular carcinoma.
Chen, Z., Xie, H., Hu, M., Huang, T., Hu, Y., Sang, N., & Zhao, Y. (2020) · PubMed Central · Cited by 372
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Llovet, J. M., Willoughby, C. E., Singal, A. G., Greten, T. F., Heikenwälder, M., El-Serag, H. B., Finn, R. S., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00754-7 · Cited by 354
Self-citationPrognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
Tandon, P., & Garcia‐Tsao, G. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01957.x · Cited by 354
Kudo, M., Chung, H., Haji, S., Osaki, Y., Oka, H., Seki, T., Kasugai, H., Sasaki, Y., & Matsunaga, T. (2004) · Hepatology · doi:10.1002/hep.20486 · Cited by 353
Iavarone, M., Cabibbo, G., Piscaglia, F., Zavaglia, C., Grieco, A., Villa, E., Cammà, C., & Colombo, M. (2010) · Hepatology · doi:10.1002/hep.24644 · Cited by 352
TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
Caja, L., Dituri, F., Mancarella, S., Caballero-Diaz, D., Moustakas, A., Giannelli, G., & Fabregat, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051294 · Cited by 351
Flecken, T., Schmidt, N., Hild, S., Gostick, E., Drognitz, O., Zeiser, R., Schemmer, P., Bruns, H., Eiermann, T., Price, D. A., et al. (2014) · Hepatology · doi:10.1002/hep.26731 · Cited by 351
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., Morse, J., Hull, D., Patman, G., Kagebayashi, C., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0870 · Cited by 350
Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl, H., Trauner, M., & Peck-Radosavljevic, M. (2013) · Hepatology · doi:10.1002/hep.26256 · Cited by 343
Llovet, J. M., & Bruix, J. (2000) · Hepatology · doi:10.1053/jhep.2000.16475 · Cited by 342
Self-citationPoulou, L. S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1054 · Cited by 340
Transarterial chemoembolization: Modalities, indication, and patient selection
Sieghart, W., Hucke, F., & Peck-Radosavljevic, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.010 · Cited by 336
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Huitzil-Melendez, F.-D., Capanu, M., O'Reilly, E. M., Duffy, A., Gansukh, B., Saltz, L. L., & Abou-Alfa, G. K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9895 · Cited by 335
Thomas, M. B., Morris, J. S., Chadha, R., Iwasaki, M., Kaur, H., Lin, E., Kaseb, A., Glover, K., Davila, M., & Abbruzzese, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3301 · Cited by 334
Staging systems in hepatocellular carcinoma
Pons, F., Varela, M., & Llovet, J. M. (2005) · HPB · doi:10.1080/13651820410024058 · Cited by 334
Self-citationMinagawa, M., Ikai, I., Matsuyama, Y., Yamaoka, Y., & Makuuchi, M. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000254368.65878.da · Cited by 330
Dimitroulis, D., Damaskos, C., Valsami, S., Davakis, S., Garmpis, N., Spartalis, E., Athanasiou, A., Moris, D., Sakellariou, S., Kykalos, S., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5282 · Cited by 330
Poté, N., Cauchy, F., Albuquerque, M., Voitot, H., Belghiti, J., Castera, L., Puy, H., Bedossa, P., & Paradis, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.005 · Cited by 328
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Yoo, B. K., Emdad, L., Su, Z.-Z., Villanueva, A., Chiang, D. Y., Mukhopadhyay, N. D., Mills, A. S., Waxman, S., Fisher, R. A., Llovet, J. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36460 · Cited by 328
Self-citationMedical therapies for hepatocellular carcinoma: a critical view of the evidence
Villanueva, A., Hernandez-Gea, V., & Llovet, J. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.199 · Cited by 314
Self-citationLiver Transplantation for Hepatocellular Carcinoma
Hemming, A. W., Cattral, M. S., Reed, A. I., Van der Werf, W. J., Greig, P. D., & Howard, R. J. (2001) · Annals of Surgery · doi:10.1097/00000658-200105000-00009 · Cited by 311
Brunello, F., Veltri, A., Carucci, P., Pagano, E., Ciccone, G., Moretto, P., Sacchetto, P., Gandini, G., & Rizzetto, M. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701885481 · Cited by 302
Sala, M., Fuster, J., Llovet, J. M., Navasa, M., Solé, M., Varela, M., Pons, F., Rimola, A., García-Valdecasas, J. C., Brú, C., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20202 · Cited by 297
Self-citationCancer and liver cirrhosis: implications on prognosis and management
Pinter, M., Trauner, M., Peck-Radosavljevic, M., & Sieghart, W. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000042 · Cited by 295
Makuuchi, M., Kokudo, N., Arii, S., Futagawa, S., Kaneko, S., Kawasaki, S., Matsuyama, Y., Okazaki, M., Okita, K., Omata, M., et al. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00216.x · Cited by 294
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.354 · Cited by 293
Ueno, S., Tanabe, G., Sako, K., Hiwaki, T., Hokotate, H., Fukukura, Y., Baba, Y., Imamura, Y., & Aikou, T. (2001) · Hepatology · doi:10.1053/jhep.2001.27219 · Cited by 292
Kang, X.-Q., Zang, W.-J., Bao, L.-J., Li, D.-L., Song, T.-S., Xu, X.-L., & Yu, X.-J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i47.7461 · Cited by 71
Pompili, M., Saviano, A., de Matthaeis, N., Cucchetti, A., Ardito, F., Federico, B., Brunello, F., Pinna, A. D., Giorgio, A., Giulini, S. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.009 · Cited by 285
Cabrera, R. (2012) · Hepatic Medicine: Evidence and Research · doi:10.2147/hmer.s16316 · Cited by 274
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
Tateishi, R., Yoshida, H., Shiina, S., Imamura, H., Hasegawa, K., Teratani, T., Obi, S., Sato, S., Koike, Y., Fujishima, T., et al. (2005) · Gut · doi:10.1136/gut.2003.035055 · Cited by 273
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
Llovet, J. M., Sala, M., Castells, L., Suarez, Y., Vilana, R., Bianchi, L., Ayuso, C., Vargas, V., Rodés, J., & Bruix, J. (2000) · Hepatology · doi:10.1002/hep.510310111 · Cited by 271
Self-citationCirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., Therneau, T. M., Kim, B., & Roberts, L. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.08.019 · Cited by 266
Serper, M., Taddei, T. H., Mehta, R., D’Addeo, K., Dai, F., Aytaman, A., Baytarian, M., Fox, R., Hunt, K., Goldberg, D. S., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.040 · Cited by 265
Golfieri, R., Cappelli, A., Cucchetti, A., Piscaglia, F., Carpenzano, M., Peri, E., Ravaioli, M., D'Errico-Grigioni, A., Pinna, A. D., & Bolondi, L. (2011) · Hepatology · doi:10.1002/hep.24246 · Cited by 264
Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems
Liu, P.-H., Hsu, C.-Y., Hsia, C.-Y., Lee, Y.-H., Su, C.-W., Huang, Y.-H., Lee, F.-Y., Lin, H.-C., & Huo, T.-I. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.029 · Cited by 263
Wang, Q., Xia, D., Bai, W., Wang, E., Sun, J., Huang, M., Mu, W., Yin, G., Li, H., Zhao, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.013 · Cited by 261
Predictors of Survival After Resection of Early Hepatocellular Carcinoma
Nathan, H., Schulick, R. D., Choti, M. A., & Pawlik, T. M. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a38eb5 · Cited by 258
Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
Brown, D. B., Gould, J. E., Gervais, D. A., Goldberg, S. N., Murthy, R., Millward, S. F., Rilling, W. S., Geschwind, J.-F. S., Salem, R., Vedantham, S., et al. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.04.021 · Cited by 257
Sanmamed, M. F., Carranza-Rua, O., Alfaro, C., Oñate, C., Martín-Algarra, S., Perez, G., Landazuri, S. F., Gonzalez, Á., Gross, S., Rodriguez, I., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3203 · Cited by 256
Teh, S. H., Christein, J., Donohue, J., Que, F., Kendrick, M., Farnell, M., Cha, S., Kamath, P., Kim, R., & Nagorney, D. M. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.09.008 · Cited by 255
Levy, I., & Sherman, M. (2002) · Gut · doi:10.1136/gut.50.6.881 · Cited by 254
Fransvea, E., Angelotti, U., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22201 · Cited by 253
and Members of the Veterans Affairs Hepatitis C Resource Center Program, Garcia-Tsao, G., & Lim, J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.191 · Cited by 251
Fong, Z. V., & Tanabe, K. K. (2014) · Cancer · doi:10.1002/cncr.28730 · Cited by 250
Hepatocellular carcinoma: present status and future prospects
Llovet, J. M., & Beaugrand, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00432-4 · Cited by 248
“French classification (score) [2] Tumour stage: portal invasion, AFP, alkaline phosphatase; liver function: bilirubin; health status: Karnofsky index Stage A (score 0) 71 38 – Stage B (score 1–5) 33 12 – Stage C (score $6) 7 3 – CLIP classification (score) [43] Tumour stage: portal invasion, morphology, AFP; liver fun…”
BackgroundMethodInfluentialSelf-citationImaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
Hennedige, T. P., & Venkatesh, S. K. (2012) · Cancer Imaging · doi:10.1102/1470-7330.2012.0044 · Cited by 249
Hiraoka, A., Kumada, T., Michitaka, K., Toyoda, H., Tada, T., Ueki, H., Kaneto, M., Aibiki, T., Okudaira, T., Kawakami, T., et al. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13250 · Cited by 245
Is Portal Hypertension a Contraindication to Hepatic Resection?
Cucchetti, A., Ercolani, G., Vivarelli, M., Cescon, M., Ravaioli, M., Ramacciato, G., Grazi, G. L., & Pinna, A. D. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b977a5 · Cited by 244
Grieco, A., Pompili, M., Caminiti, G., Miele, L., Covino, M., Alfei, B., Rapaccini, G. L., & Gasbarrini, G. (2005) · Gut · doi:10.1136/gut.2004.048124 · Cited by 242
Ng, K. K., Vauthey, J.-N., Pawlik, T. M., Lauwers, G. Y., Regimbeau, J.-M., Belghiti, J., Ikai, I., Yamaoka, Y., Curley, S. A., Nagorney, D. M., et al. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.06.004 · Cited by 241
Bräu, N., Fox, R. K., Xiao, P., Marks, K., Naqvi, Z., Taylor, L. E., Trikha, A., Sherman, M., Sulkowski, M. S., Dieterich, D. T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.010 · Cited by 239
Self-citationThe treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
Galle, P. R., Tovoli, F., Foerster, F., Wörns, M. A., Cucchetti, A., & Bolondi, L. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.007 · Cited by 236
Huang, M.-D., Chen, W.-M., Qi, F.-Z., Sun, M., Xu, T.-P., Ma, P., & Shu, Y.-Q. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0431-0 · Cited by 236
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Pawlik, T. M., Poon, R. T., Abdalla, E. K., Ikai, I., Nagorney, D. M., Belghiti, J., Kianmanesh, R., Oi-Lin Ng, I., Curley, S. A., Yamaoka, Y., et al. (2005) · Surgery · doi:10.1016/j.surg.2004.12.012 · Cited by 235
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Llovet, J. M., Montal, R., & Villanueva, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.028 · Cited by 233
Self-citationPretreatment assessment of hepatocellular carcinoma: expert consensus statement
Vauthey, J., Dixon, E., Abdalla, E. K., Helton, W. S., Pawlik, T. M., Taouli, B. A., Brouquet, A., & Adams, R. B. (2010) · HPB · doi:10.1111/j.1477-2574.2010.00181.x · Cited by 231
Sun, N., Lee, Y.-T., Zhang, R. Y., Kao, R., Teng, P.-C., Yang, Y., Yang, P., Wang, J. J., Smalley, M., Chen, P.-J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18311-0 · Cited by 230
Treatment Strategies for Hepatocellular Carcinoma—A Multidisciplinary Approach
Lurje, I., Czigany, Z., Bednarsch, J., Roderburg, C., Isfort, P., Neumann, U. P., & Lurje, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061465 · Cited by 229
Hepatocellular carcinoma in Central Europe: prognostic features and survival
Schöniger-Hekele, M., Müller, C., Kutilek, M., Oesterreicher, C., Ferenci, P., & Gangl, A. (2001) · Gut · doi:10.1136/gut.48.1.103 · Cited by 228
Huang, G., Lau, W. Y., Wang, Z.-G., Pan, Z.-Y., Yuan, S.-X., Shen, F., Zhou, W.-P., & Wu, M.-C. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000858 · Cited by 227
Veltri, A., Moretto, P., Doriguzzi, A., Pagano, E., Carrara, G., & Gandini, G. (2006) · European Radiology · doi:10.1007/s00330-005-0029-9 · Cited by 224
Review article: the management of hepatocellular carcinoma
CABRERA, R., & NELSON, D. R. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04200.x · Cited by 222
Mornex, F., Girard, N., Beziat, C., Kubas, A., Khodri, M., TREPO, C. G., & Merle, P. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.06.015 · Cited by 222
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
Reig, M., Sanduzzi-Zamparelli, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Díaz, A., Llarch, N., Iserte, G., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2025.10.020 · Cited by 220
Self-citationHepatitis B Virus-Associated Hepatocellular Carcinoma
Rizzo, G. E. M., Cabibbo, G., & Craxì, A. (2022) · Viruses · doi:10.3390/v14050986 · Cited by 220
Demirtas, C. O., D’Alessio, A., Rimassa, L., Sharma, R., & Pinato, D. J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100347 · Cited by 219
Hyun, M. H., Lee, Y., Kim, J. H., Lee, C. U., Jung, Y. K., Seo, Y. S., Yim, H. J., Yeon, J. E., & Byun, K. S. (2018) · Hepatology · doi:10.1002/hep.29883 · Cited by 219
Omata, M., Tateishi, R., Yoshida, H., & Shiina, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.030 · Cited by 215
Current management of hepatocellular carcinoma.
Crissien, A. M., & Frenette, C. T. (2014) · Europe PMC (PubMed Central) · Cited by 215
Epidemiology and Management of Hepatocellular Carcinoma
Yang, J. D., & Roberts, L. R. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.004 · Cited by 213
Wen, N., Cai, Y., Li, F., Ye, H., Tang, W., Song, P., & Cheng, N. (2022) · BioScience Trends · doi:10.5582/bst.2022.01061 · Cited by 211
Sturgeon, C. M., Duffy, M. J., Hofmann, B. R., Lamerz, R., Fritsche, H. A., Gaarenstroom, K., Bonfrer, J., Ecke, T. H., Grossman, H. B., Hayes, P., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.133124 · Cited by 211
Kisiel, J. B., Dukek, B. A., V.S.R. Kanipakam, R., Ghoz, H. M., Yab, T. C., Berger, C. K., Taylor, W. R., Foote, P. H., Giama, N. H., Onyirioha, K., et al. (2019) · Hepatology · doi:10.1002/hep.30244 · Cited by 210
Arizumi, T., Ueshima, K., Minami, T., Kono, M., Chishina, H., Takita, M., Kitai, S., Inoue, T., Yada, N., Hagiwara, S., et al. (2015) · Liver Cancer · doi:10.1159/000367743 · Cited by 207
Vitale, A., Cabibbo, G., Iavarone, M., Viganò, L., Pinato, D. J., Ponziani, F. R., Lai, Q., Casadei-Gardini, A., Celsa, C., Galati, G., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00186-9 · Cited by 206
Herrero, I. J., Sangro, B., Quiroga, J., Pardo, F., Herraiz, M., Cienfuegos, J. A., & Prieto, J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25458 · Cited by 205
Finkelmeier, F., Canli, Ö., Tal, A., Pleli, T., Trojan, J., Schmidt, M., Kronenberger, B., Zeuzem, S., Piiper, A., Greten, F. R., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.03.002 · Cited by 204
Pawlik, T. M., Gleisner, A. L., Anders, R. A., Assumpcao, L., Maley, W., & Choti, M. A. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000250420.73854.ad · Cited by 203
Dempsey, D. T. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70399-4 · Cited by 201
Marasco, G., Colecchia, A., Colli, A., Ravaioli, F., Casazza, G., Bacchi Reggiani, M. L., Cucchetti, A., Cescon, M., & Festi, D. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.022 · Cited by 200
A new classification for hepatocellular carcinoma with portal vein tumor thrombus
Shi, J., Lai, E. C. H., Li, N., Guo, W., Xue, J., Lau, W., Wu, M., & Cheng, S. (2010) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-010-0314-0 · Cited by 199
Assessment of liver function for safe hepatic resection
Seyama, Y., & Kokudo, N. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00441.x · Cited by 198
Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
Pinter, M., Hucke, F., Graziadei, I., Vogel, W., Maieron, A., Königsberg, R., Stauber, R., Grünberger, B., Müller, C., Kölblinger, C., et al. (2012) · Radiology · doi:10.1148/radiol.12111550 · Cited by 197
Risk Factors and Management of Ascites After Liver Resection to Treat Hepatocellular Carcinoma
Ishizawa, T., Hasegawa, K., Kokudo, N., Sano, K., Imamura, H., Beck, Y., Sugawara, Y., & Makuuchi, M. (2009) · Archives of Surgery · doi:10.1001/archsurg.2008.511 · Cited by 197
Kudo, M., & Okanoue, T. (2007) · Oncology · doi:10.1159/000111702 · Cited by 196
Huang, H., Ren, Z., Gao, X., Hu, X., Zhou, Y., Jiang, J., Lu, H., Yin, S., Ji, J., Zhou, L., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00796-5 · Cited by 195
Cillo, U., Bassanello, M., Vitale, A., Grigoletto, F. A., Burra, P., Fagiuoli, S., D'Amico, F., Ciarleglio, F. A., Boccagni, P., Brolese, A., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.09.027 · Cited by 195
Wang, J.-H., Changchien, C.-S., Hu, T.-H., Lee, C.-M., Kee, K.-M., Lin, C.-Y., Chen, C.-L., Chen, T.-Y., Huang, Y.-J., & Lu, S.-N. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.018 · Cited by 195
Margarit, C., Escartín, A., Castells, L., Vargas, V., Allende, E., & Bilbao, I. (2005) · Liver Transplantation · doi:10.1002/lt.20398 · Cited by 194
Mokrane, F.-Z., Lu, L., Vavasseur, A., Otal, P., Peron, J.-M., Luk, L., Yang, H., Ammari, S., Saenger, Y., Rousseau, H., et al. (2020) · European Radiology · doi:10.1007/s00330-019-06347-w · Cited by 193
Moris, D., Martinino, A., Schiltz, S., Allen, P. J., Barbas, A. S., Sudan, D. L., King, L. Y., Berg, C. L., Kim, C., Bashir, M. R., et al. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70018 · Cited by 195
Glazer, E. S., Piccirillo, M., Albino, V., Di Giacomo, R., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., De Rosa, V., Petrillo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7765 · Cited by 187
Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma
Livraghi, T., Lazzaroni, S., Meloni, F., & Solbiati, L. (2005) · British Journal of Surgery · doi:10.1002/bjs.4986 · Cited by 185
Present and future possibilities for early diagnosis of hepatocellular carcinoma
Stefaniuk, P. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.418 · Cited by 184
Metadata
- Authors
- Llovet, J., Brú, C., & Bruix, J.
- Affiliations
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 19
- Issue
- 03
- Pages
- 329-338
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2147172608
- Cited by
- 3,805
- References
- 0
- Citations by year
- 2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.